Evidence map›Paper›PMID 28751560›Full record

ArticleHaematologica2017

Mutational status of

Pietro Bulian, Riccardo Bomben, Michele Dal Bo, Antonella Zucchetto, Francesca Maria Rossi, Massimo Degan, Federico Pozzo, Tamara Bittolo, Vanessa Bravin, Tiziana D'Agaro and 14 more

Open access · goldAbstract readLetter
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. A large fraction of trisomy 12, 17pProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 3 countries.

Pietro BulianClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy pbulian@cro.it.
Riccardo BombenClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Michele Dal BoClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Antonella ZucchettoClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Francesca Maria RossiClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Massimo DeganClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Federico PozzoClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Tamara BittoloClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Vanessa BravinClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Tiziana D'AgaroClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Michaela CerriDivision of Hematology - Department of Translational Medicine - Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
Annalisa ChiarenzaDivision of Hematology, Ferrarotto Hospital, Catania, Italy.
Kari G ChaffeeDepartment of Hematology, Mayo Clinic, Rochester, MN, USA.
Adalgisa CondoluciOncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
Giovanni D'ArenaIRCCS, Referral Cancer Center of Basilicata, Potenza, Italy.
Michele SpinaOncologia Medica A IRCCS, Centro di Riferimento Oncologico, Aviano, Italy.
Francesco ZajaClinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy.
Gabriele PozzatoDepartment of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Italy.
Francesco Di RaimondoDivision of Hematology, Ferrarotto Hospital, Catania, Italy.
Davide RossiOncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
Giovanni Del PoetaDivision of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
Gianluca GaidanoDivision of Hematology - Department of Translational Medicine - Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
Tait D ShanafeltDepartment of Hematology, Mayo Clinic, Rochester, MN, USA.
Valter GatteiClinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITCentro di Riferimento Oncologico · ITFerrarotto Hospital · ITInstitute of Oncology Research · CHMayo Clinic in Arizona · USUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITAzienda Ospedaliera S.Maria · ITCentro di Riferimento Oncologico della Basilicata · ITSt. Eugenio Hospital · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chromosomes, Human, Pair 12Genes, Immunoglobulin Heavy ChainMutationTrisomyBiomarkersHumansKaplan-Meier EstimateLeukemia, Lymphocytic, Chronic, B-CellPrognosisProportional Hazards ModelsBiomarkers

Identifiers

PMID28751560
PMCPMC5664405
OpenAlexW2737663958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.